CG Oncology (CGON) Preferred Dividend Payments (2023)

CG Oncology's (CGON) quarterly Preferred Dividend Payments came in at $410000.0 in Q3 2023, down 89.14% on a QoQ basis from $3.8 million in Q2 2023.

Analysis

CG Oncology (CGON) Preferred Dividend Payments (2023) Analysis & Trends

CG Oncology (CGON) has 1 years of Preferred Dividend Payments data on file, last reported at $410000.0 in Q3 2023.

Quarterly Preferred Dividend Payments changed N/A year-over-year to $410000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2024 was $410000.0 (changed N/A YoY) and the FY2023 annual result came in at $410000.0, changed N/A from the prior year.
Preferred Dividend Payments declined to $410000.0 in Q3 2023, from $3.8 million in the prior quarter.
In the past five years, Preferred Dividend Payments ranged from a high of $3.8 million in Q2 2023 to a low of $410000.0 in Q3 2023.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Vertex Pharmaceuticals	138.78 Bn	130.92 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.50 Bn	77.51 Bn	3.93 Bn	-
3	Argenx Se	63.51 Bn	58.32 Bn	1.37 Bn	-
4	Moderna	58.06 Bn	52.92 Bn	52.00 Mn	-
5	Revolution Medicines	44.04 Bn	44.04 Bn	-	-
6	BeOne Medicines	40.04 Bn	34.94 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.45 Bn	32.14 Bn	992.69 Mn	-
8	Royalty Pharma	28.41 Bn	27.57 Bn	-	-
9	Insmed	27.42 Bn	26.26 Bn	358.27 Mn	-
10	CG Oncology	6.56 Bn	6.56 Bn	-2.77 Mn	-

Historic Data

Download Data